Matthew B. Klein, CHIEF EXECUTIVE OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 21,478 shares at $51.74 ($1.1M) on 2025-08-05, disclosed to the SEC on 2025-08-05.
Scheduled sale ($1.1M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.74 | 10,739 | $556K | 50.0% |
| 2 | $51.74 | 10,739 | $556K | 50.0% |
| Total | $51.74 avg | 21,478 | $1.1M | 100% |
| Filing → |
| PTCT | SELL | 2026-05-15 | $917K | — | Filing → |
| PTCT | SELL | 2026-04-23 | $202K | — | Filing → |
| PTCT | SELL | 2026-03-13 | $171K | — | Filing → |